Equity Profile

CVS

CVS Health Corporation

Health CareHealth Care Services$135.1B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

CVS Health Corporation is a leading health care services company that operates a chain of pharmacies and provides health insurance services. With a market cap of $135 billion, CVS plays a crucial role in the health care sector, especially as consumer spending on health services continues to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well CVS is managing its costs and revenue.

N/A

Revenue Growth

Revenue growth will indicate how well CVS is expanding its business and capturing market share in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, exceeding expectations by 16.39%. The stock reacted positively, gaining 7.65% the following day.

Management Promises & Guidance

Commitment to improving pharmacy services.
Focus on expanding health care offerings.
Plans to enhance digital health solutions.

Expectations

Wall Street Expectations

Analysts are generally optimistic about CVS's upcoming earnings, especially given its strong performance in the previous quarter.

Bull Case

If CVS continues its trend of beating EPS estimates, it could signal strong operational efficiency and market demand.

Bear Case

Concerns about rising costs and competition in the health care sector could lead to disappointing results.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability and will heavily influence investor sentiment and stock performance.

How are pharmacy sales trending compared to last quarter?

Pharmacy sales are a major revenue driver, and any slowdown could raise concerns about CVS's market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate CVS's ability to leverage its pharmacy network for growth, especially in digital health services.

Supporting Evidence

CVS's recent investments in technology could enhance customer engagement and drive sales.

The company's strong track record of beating EPS estimates indicates operational resilience.

Options pricing suggests higher volatility, which may reflect underlying confidence in CVS's performance.

Key Risk

If pharmacy sales show unexpected growth, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether CVS can maintain its growth trajectory amidst rising competition and operational challenges.

Bull Confirmed If

EPS growth of over 10% compared to the previous quarter would confirm strong operational performance.

Bear Confirmed If

A decline in pharmacy sales or an EPS below $2.50 would raise red flags about CVS's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 4.06%, confirming strong operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A disappointing earnings report could lead to a decline, with historical patterns suggesting a drop of around 5.45%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

Senate only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-ARJohn BoozmanSen.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on digital health initiatives and their impact on sales.
2Any changes in guidance regarding pharmacy sales growth.
3Insights into cost management strategies in response to rising expenses.
4Details on customer engagement strategies and their effectiveness.
5Management's outlook on competition and market positioning.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well CVS is managing its costs and revenue.

N/A

Revenue Growth

Revenue growth will indicate how well CVS is expanding its business and capturing market share in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, exceeding expectations by 16.39%. The stock reacted positively, gaining 7.65% the following day.

Management Promises & Guidance

Commitment to improving pharmacy services.
Focus on expanding health care offerings.
Plans to enhance digital health solutions.

Expectations

Wall Street Expectations

Analysts are generally optimistic about CVS's upcoming earnings, especially given its strong performance in the previous quarter.

Bull Case

If CVS continues its trend of beating EPS estimates, it could signal strong operational efficiency and market demand.

Bear Case

Concerns about rising costs and competition in the health care sector could lead to disappointing results.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability and will heavily influence investor sentiment and stock performance.

How are pharmacy sales trending compared to last quarter?

Pharmacy sales are a major revenue driver, and any slowdown could raise concerns about CVS's market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate CVS's ability to leverage its pharmacy network for growth, especially in digital health services.

Supporting Evidence

CVS's recent investments in technology could enhance customer engagement and drive sales.

The company's strong track record of beating EPS estimates indicates operational resilience.

Options pricing suggests higher volatility, which may reflect underlying confidence in CVS's performance.

Key Risk

If pharmacy sales show unexpected growth, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether CVS can maintain its growth trajectory amidst rising competition and operational challenges.

Bull Confirmed If

EPS growth of over 10% compared to the previous quarter would confirm strong operational performance.

Bear Confirmed If

A decline in pharmacy sales or an EPS below $2.50 would raise red flags about CVS's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 4.06%, confirming strong operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A disappointing earnings report could lead to a decline, with historical patterns suggesting a drop of around 5.45%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

Senate only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-ARJohn BoozmanSen.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on digital health initiatives and their impact on sales.
2Any changes in guidance regarding pharmacy sales growth.
3Insights into cost management strategies in response to rising expenses.
4Details on customer engagement strategies and their effectiveness.
5Management's outlook on competition and market positioning.